Your browser doesn't support javascript.
loading
Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy.
Ravirala, Divya; Mistretta, Brandon; Gunaratne, Preethi H; Pei, Guangsheng; Zhao, Zhongming; Zhang, Xiaoliu.
Afiliação
  • Ravirala D; Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
  • Mistretta B; Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
  • Gunaratne PH; UH Seq-N-Edit Core, Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
  • Pei G; Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
  • Zhao Z; UH Seq-N-Edit Core, Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
  • Zhang X; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
J Immunother Cancer ; 9(7)2021 07.
Article em En | MEDLINE | ID: mdl-34230110
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simplexvirus / Anticorpos Biespecíficos / Vírus Oncolíticos / Terapia Viral Oncolítica Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simplexvirus / Anticorpos Biespecíficos / Vírus Oncolíticos / Terapia Viral Oncolítica Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article